Contribution of genotypes in Prothrombin and Factor V Leiden to COVID‐19 and disease severity in patients at high risk for hereditary thrombophilia
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Aslıhan Kiraz und 49 weiteren Autor:innen. Beteiligte Einrichtung: Kayseri City Training and Research Hospital, Genetic Diseases Evaluation Center, Kayseri, Turkey. Hauptthemen laut MEDLINE: COVID-19, Thrombophilia, Thrombosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Thrombotic and microangiopathic effects have been reported in COVID‐19 patients. This study examined the contribution of the hereditary thrombophilia factors Prothrombin (FII) and Factor V Leiden (FVL) genotypes to the severity of COVID‐19 disease and the development of thrombosis. This study investigated FII and FVL alleles in a cohort of 9508 patients (2606 male and 6902 female) with thrombophilia. It was observed that 930 of these patients had been infected by SARS‐CoV‐2 causing COVID‐19. The demographic characteristics of the patients and their COVID‐19 medical history were recorded. Detailed clinical manifestations were analyzed in a group of cases ( n = 4092). This subgroup was age and gender‐matched. FII and FVL frequency data of healthy populations without thrombophilia risk were obtained from Bursa Uludag University Medical Genetic Department's Exome Databank. The ratio of males (31.08%; 27.01%) and the mean age (36.85 ± 15.20; 33.89 ± 14.14) were higher among COVID‐19 patients compared to non‐COVID‐19 patients. The prevalence of FVL and computerized tomography (CT) positivity in COVID‐19 patients was statistically significant in the thrombotic subgroup ( p < 0.05). FVL prevalence, CT positivity rate, history of thrombosis, and pulmonary thromboembolism complication were found to be higher in deceased COVID‐19 patients ( p < 0.05). Disease severity was mainly affected by FVL and not related to genotypes at the Prothrombin mutations. Overall, disease severity and development of thrombosis in COVID‐19 are mainly affected by the variation within the FVL gene. Possible FVL mutation should be investigated in COVID‐19 patients and appropriate treatment should be started earlier in FVL‐positive patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kayseri City Training and Research Hospital, Genetic Diseases Evaluation Center, Kayseri, Turkey.
- Samsun Training and Research Hospital, Genetic Diseases Evaluation Center, Samsun, Turkey.
- Department of Translational Medicine, Institute of Health Sciences, Bursa Uludag University, Bursa, Turkey.
- Umraniye Training and Research Hospital, Genetic Diseases Evaluation Center, Health Sciences University, Istanbul, Turkey.
- Department of Medical Genetics, Dragos Hospital, Bezmialem Vakıf University, Istanbul, Turkey.
- Medical Genetics Department of Medical Faculty, AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Cukurova University, Adana, Turkey.
ORCID-Profile: Aslıhan Kiraz, Ozlem Sezer, Hakan Gurkan, Sehime Gulsun Temel
Zitieren
APA
Kiraz, A., Sezer, O., Alemdar, A., Canbek, S., Duman, N., Bisgin, A., Cora, T., Ruhi, H. I., Ergoren, M. C., Geçkinli, B. B., Sag, S. O., Gözden, H. E., Oz, O., Altıntaş, Z. M., Yalcıntepe, S., Keskin, A., Tak, A. Y., Paskal, Ş. A., Yürekli, U. F., …, & Temel, S. G. (2023). Contribution of genotypes in Prothrombin and Factor V Leiden to COVID‐19 and disease severity in patients at high risk for hereditary thrombophilia. Journal of Medical Virology. https://doi.org/10.1002/jmv.28457
Vancouver
Kiraz A, Sezer O, Alemdar A, Canbek S, Duman N, Bisgin A, et al. Contribution of genotypes in Prothrombin and Factor V Leiden to COVID‐19 and disease severity in patients at high risk for hereditary thrombophilia. Journal of Medical Virology. 2023. doi:10.1002/jmv.28457
BibTeX
@article{Kiraz2023,
author = {Kiraz, Aslıhan and Sezer, Ozlem and Alemdar, Adem and Canbek, Sezin and Duman, Nilgun and Bisgin, Atıl and Cora, Tulin and Ruhi, Hatice Ilgın and Ergoren, Mahmut Cerkez and Geçkinli, Bilgen Bilge and Sag, Sebnem Ozemri and Gözden, Hilmi Erdem and Oz, Ozlem and Altıntaş, Zuhal Mert and Yalcıntepe, Sinem and Keskin, Adem and Tak, Ayşegül Yabacı and Paskal, Şeyma Aktaş and Yürekli, Uğur Fahri and Demirtas, Mercan and Evren, Emine Unal and Hanta, Abdullah and Başdemirci, Müşerref and Suer, Kaya and Balta, Burhan and Kocak, Nadir and Karabulut, Halil Gürhan and Cobanogulları, Havva and Ateş, Esra Arslan and Bozdoğan, Sevcan Tuğ and Eker, Damla and Ekinci, Sadiye and Nergiz, Süleyman and Tuncalı, Timur and Yagbasan, Serap and Alavanda, Ceren and Kutlay, Nuket Yurur and Evren, Hakan and Erdoğan, Murat and Altıner, Sule and Sanlidag, Tamer and Gonen, Gizem Akıncı and Vicdan, Arzu and Eras, Nazan and Eker, Hatice Koçak and Balasar, Ozgür and Tuncel, Gulten and Dundar, Munis and Gurkan, Hakan and Temel, Sehime Gulsun},
title = {Contribution of genotypes in Prothrombin and Factor V Leiden to COVID‐19 and disease severity in patients at high risk for hereditary thrombophilia},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28457}
}
EUVIMED